• 제목/요약/키워드: Gastritis

검색결과 485건 처리시간 0.034초

미란성 위염 환자 K43에서 재발성 요로 결석에 관한 연구 (Assessment of Relapsing Urolithiasis from K43 with Erosive Gastritis)

  • 김재웅
    • 한국식품영양학회지
    • /
    • 제10권1호
    • /
    • pp.44-52
    • /
    • 1997
  • 요석증은 비뇨기과에서 흔히 관찰되는 질환으로서 30∼50대에 많이 발생하고, 남자가 여자보다 발생빈도가 높고, 좌측보다는 우측이 많으며, 문화가 발달한 나라에서는 상부요로 결석이 많으나 후진국에서는 하부요로 결석이 많다. 결석성분은 수산칼슘, 인산칼슘, 인산마그네슘암모늄, 요산, 시스틴 결석과 그들의 혼합결석으로 분류된다. 병태 생리학에 따르면, 결석의 발생원인은 요중의 무기질 농도가 과포화 상태가 되면 결정체핵이 생성된다는 과포화/결정체설, 기질관여설, 억제물질의 결핍설, 에피택시설 등이 있고, 상피소체기능항진중, 과칼슘뇨증, 과요산뇨증, 과수산뇨증, 시스틴뇨증 외에도 원위세뇨관 산증, 과비타민 D증, 소화기계 질환이 통계적으로 유의성 있게 관여된다는 것이다. 본 연구에서는 미란성 위염 환자 K43에서 화학분석법, 적외선 흡수 분석법, image analysis법을 사용하여 재발성 상부요로 결석성분을 분석한 결과 제2 수산칼슘과 인산칼슘의 혼합결석으로 확인되었고, 혈액화학 검사와 요 검사 등 임상검사 성적은 정상치를 유지하고 있었다. 따라서 K43의 재발성 요로결석은 보고된 생성원인이나 인자들에 대한 통계수치와는 연관성이 없었으며 미란성 위염으로부터 영향을 받았다는 증거도 없었다.

  • PDF

The Effect of $Luteolin-7-O-{\beta}-D-Glucuronopyranoside$ on Gastritis and Esophagitis in Rats

  • Min, Young-Sil;Bai, Ki-Lyong;Yim, Sung-Hyuk;Lee, Young-Joo;Song, Hyun-Ju;Kim, Jin-Hak;Ham, In-Hye;Whang, Wan-Kyun;Sohn, Uy-Dong
    • Archives of Pharmacal Research
    • /
    • 제29권6호
    • /
    • pp.484-489
    • /
    • 2006
  • This Study evaluated the inhibitory action of $luteolin-7-O-{\beta}-D-glucuronopyranoside$, luteolin which was isolated from Salix gilgiana leaves, and omeprazole on reflux esophagitis and gastritis in rats. Reflux esophagitis and gastritis were induced surgically and by the administration of indomethacin, respectively. The intraduodenal administration of $luteolin-7-O-{\beta}-D-glucuronopyranoside$ decreased the ulcer index, injury area, gastric volume and acid output, and increased the gastric pH compared with luteolin. $Luteolin-7-O-{\beta}-D-glucuronopyranoside$ significantly decreased the size of the gastric lesions that had been induced by exposing the gastric mucosa to indomethacin. The malondialdehyde content, which is the end product of lipid peroxidation, was increased significantly after inducing of reflux esophagitis. The malondialdehyde content was decreased by $Luteolin-7-O-{\beta}-D-glucuronopyranoside$ but not luteolin or omeprazole. $Luteolin-7-O-{\beta}-D-glucuronopyranoside$ has a more potent antioxidative effect than luteolin. $Luteolin-7-O-{\beta}-D-glucuronopyranoside$ is a promising drug for the treatment of reflux esophagitis and gastritis.

Atrophic Gastritis Concurrent with Helicobacter Infection in Two Dogs

  • An, Su-Jin;Eom, Na-Young;Lee, Hee-Chun;Sur, Jung-Hyang;Park, Chul;So, Kyung-Min;Jung, Dong-In
    • 한국임상수의학회지
    • /
    • 제33권5호
    • /
    • pp.286-289
    • /
    • 2016
  • Two dogs (Case 1: Poodle, 4 years old, spayed female; Case 2: Bulldog, 3 years old, intact female) were referred to us for treatment of vomiting; Case 1 had a history of acute vomiting that started 1 day prior to presentation, and Case 2 had a history of chronic vomiting that started 2 years prior to presentation. The vomiting did not respond to medication in the local animal hospital. Results from abdominal ultrasound examinations showed that case 1 had gastric wall thickening, and case 2 had no remarkable findings. For both cases, we performed gastrointestinal endoscopic examinations, and several biopsy samples were obtained from different gastric areas. On the basis of the results of histopathological examinations, both dogs were diagnosed with atrophic gastritis concurrent with a Helicobacter infection. Clinical signs improved after antibiotic therapy. This case report describes the clinical, endoscopic, and histopathological findings of atrophic gastritis concurrent with a Helicobacter infection.

소화기 질환 동물모델에서 평위산(平胃散)의 염증 완화 효과 (Comparative Efficacy Study of Pyeongwi-san(Pingwei-san) of Digestive Tract Disease Model in Rat)

  • 정세영;정성은;김지혜;함성호;양웅모;권보인
    • 대한본초학회지
    • /
    • 제35권2호
    • /
    • pp.7-14
    • /
    • 2020
  • Objectives : Pyeongwi-san is widely used in Korean medicine for acute indigestion or gastrodynia. As a therapeutic agent for digestive diseases of modern people, in order to confirm the mechanism of Pyeongwi-san on digestive tract disease and the difference of therapeutic efficacy between its formulation, a comparative efficacy test was conducted on digestive tract disease animal model. Methods : For LPS enteritis animal model, male SD rats were intraorally treated with different formulation types of Pyeongwi-san, and then intraperitoneally administered LPS one hour later to induce enteritis. After 5 hours, blood was collected and TNFα, IL-1β, IL-6 and PGE2 were confirmed by ELISA. For acute gastritis animal model, male SD rats were intraorally treated with different formulation types of Pyeongwi-san according to the prescribed concentration, and then intraorally administered 60% ethanol and 150 mM HCl one hour later to induce acute gastritis. After 5 hours, blood was collected and TNFα,IL-6 were confirmed by ELISA. Results : In the LPS-administered enteritis animal model, Pyeongwi-san decreased TNFα, IL-1β, PGE2 and especially IL-6. Pyeongwi-san also decreased IL-6 in acute gastritis animal model. In addition, there was no significant difference in efficacy between the two formulations when compared with inflammatory markers. Conclusions : The efficacy of Pyeongwi-san was confirmed in the inflammatory markers related to digestive inflammatory diseases, and the efficay between two formulations of Pyeongwi-san was relatively similar. Further studies are needed to investigate the new applicability of Pyeongwi-san on different inflammatory diseases that have similar inflammation markers identified in this experiment.

Anti-microbial and anti-inflammatory effects of Cheonwangbosim-dan against Helicobacter pylori-induced gastritis

  • Park, Hee-Seon;Jeong, Hye-Yun;Kim, Young-Suk;Seo, Chang-Seob;Ha, Hyekyung;Kwon, Hyo-Jung
    • Journal of Veterinary Science
    • /
    • 제21권3호
    • /
    • pp.39.1-39.15
    • /
    • 2020
  • Background: There are various Helicobacter species colonizing the stomachs of animals. Although Helicobacter species usually cause asymptomatic infection in the hosts, clinical signs can occur due to gastritis associated with Helicobacter in animals. Among them, Helicobacter pylori is strongly associated with chronic gastritis, gastric ulcers, and gastric cancers. As the standard therapies used to treat H. pylori have proven insufficient, alternative options are needed to prevent and eradicate the diseases associated with this bacterium. Cheonwangbosim-dan (CBD), a traditional herbal formula that is popular in East Asia, has been commonly used for arterial or auricular flutter, neurosis, insomnia, and cardiac malfunction-induced disease. Objectives: The present study investigated the antimicrobial effect of CBD on H. pylori-infected human gastric carcinoma AGS cells and model mice. Methods: AGS cells were infected with H. pylori and treated with a variety of concentrations of CBD or antibiotics. Mice were given 3 oral inoculations with H. pylori and then dosed with CBD (100 or 500 mg/kg) for 4 weeks or with standard antibiotics for 1 week. One week after the last treatment, gastric samples were collected and examined by histopathological analysis, real-time quantitative polymerase chain reaction, and immunoblotting. Results: Our results showed that CBD treatment of AGS cells significantly reduced the H. pylori-induced elevations of interleukin-8, inducible nitric oxide synthase (iNOS), and cyclooxygenase-2 (COX-2). In the animal model, CBD treatment inhibited the colonization of H. pylori and the levels of malondialdehyde, inflammation, proinflammatory cytokines, iNOS, and COX-2 in gastric tissues. CBD also decreased the phosphorylation levels of p38 mitogen-activated protein kinase family. Conclusions: This study suggests that CBD might be a prospective candidate for treating H. pylori-induced gastric injury.

만성위염 환자들과 위궤양 환자들 간의 스트레스반응, 분노표현 및 감정표현불능증의 비교 (The Comparison of Stress Responses, Anger Expression and Alexithymia between Chronic Gastritis and Gastric Ulcer Patients)

  • 고경봉;오승준;이성희;이상인;정재복
    • 정신신체의학
    • /
    • 제12권1호
    • /
    • pp.30-37
    • /
    • 2004
  • 연구목적: 본 연구는 만성표재성 위염 환자들과 위궤양 환자들을 대상으로 두 환자군 간의 스트레스반응, 분노표현, 감정표현불능증을 비교하기 위해 시행되었다. 방 법: 대상은 소화기내과에 내원한 후 위내시경을 시행하여 만성표재성위염으로 확인된 환자 100명과 위궤양으로 확인된 환자 40명으로 구성되었다. 스트레스반응은 스트레스반응척도 및 Symptom Checklist-90-revised의 불안, 우울, 신체화, 적대감 하위척도에 의해, 분노표현은 분노표현척도에 의해, 감정표현불능증은 Toronto Alexithymia Scale에 의해 각각 평가되었다. 결 과: 만성위염 환자들이 위궤양 환자들보다 스트레스반응척도의 긴장 하위척도 및 신체화 하위척도 점수와 SCL-90-R의 불안 하위척도 점수가 각각 유의하게 더 높았다. 그러나 분노표현 하위척도 및 분노억제 하위척도 점수와 감정표현불능증 전체점수는 2군 간에 각각 유의한 차이를 보이지 않았다. 스트레스반응척도의 신체화 하위척도 점수는 만성위염 환자들에서 여자가 남자보다, 위궤양 환자들에서는 남자가 여자보다 각각 유의하게 더 높았다. 결 론: 이상의 결과들은 만성위염 환자들이 위궤양 환자들에 비해 스트레스반응이 더 현저하고 스트레스에 대한 취약성이 더 높을 가능성을 시사해 준다. 그리고 만성위염 환자들은 여자들에서, 위궤양 환자들은 남자들에서 신체화 경향이 더 높음을 시사한다. 그러나 두 군 간에 분노표현 및 분노억압, 감정표현불능증은 차이를 보이지 않았다.

  • PDF

소아의 Helicobacter pylori 감염에 의한 결절성 위염의 유전자 발현 양상 분석 (Analysis of Gene Expression in Helicobacter pylori-associated Nodular Gastritis in Children Using Microarray)

  • 양혜란;고재성;서정기
    • Pediatric Gastroenterology, Hepatology & Nutrition
    • /
    • 제13권1호
    • /
    • pp.7-22
    • /
    • 2010
  • 목 적: Helicobacter pylori (H. pylori)에 감염된 환자에서 나타나는 결절성 위염은 소아에 특징적인 소견이지만, 지금까지 이에 대한 연구가 이루어지지 못 하였다. 본 연구에서는 H. pylori 감염이 없는 소아 환자의 위 점막의 유전자 발현 양상과 H. pylori에 감염에 의한 결절성 위염이 있는 소아 및 결절성 위염이 없는 소아의 위 점막 유전자 발현 양상을 microarray를 이용하여 비교함으로써 H. pylori 감염 시에 소아의 위 점막에 나타나는 유전자 발현 양상의 변화를 규명하고자 하였다. 방 법: 분당서울대학교 소아청소년과에 내원하여 상 부위장관내시경검사에 의한 위 점막 조직검사를 시행받은 12명의 소아청소년을 대상으로 하였다. 이들을 H. pylori 양성이면서 육안적인 병변이 없는 환아 4명의 HP(+)NG(-)군과, 위 전정부에서 결절성 위염 소견이 관찰된 환아 4명의 HP(+)NG(+)군으로 나누고, 연령 및 성별이 일치하는 H. pylori 음성인 4명의 소아를 대조군인 HP(-)NG(-)군으로 분류하였다. $-70^{\circ}C$에 냉동보관한 위 점막 조직에서 RNA를 추출하여 microarray를 시행하고 분석된 결과에 의거하여 발현 정도에 변화가 있는 유전자를 분석하였다. 결 과: 대상 환자 12명(남자 6명, 여자 6명, 평균 연령 9.8세)의 위 점막 조직에서 cDNA microarray 시행하여 H. pylori 감염의 유무에 따라 유전자 발현 정도를 비교하였을때, H. pylori 감염된 위 점막은 감염되지 않은 소아에 비해 182개의 유전자가 과발현 되었으며, 29개의 유전자가 발현이 저하되었다. H. pylori 감염이 확인 된 8명을 결절성 위염의 유무에 따라 유전자 발현 정도를 비교분석하였을 때, 상부위장관 내시경검사에서 H. pylori 감염과 연관된 결절성 위염을 보인 환자의 위 점막은 결절성 위염이 없는 H. pylori 감염 환아의 위 점막조직에 비해 5개의 유전자가 발현이 증가하였으며 5개의 유전자가 발현이 저하되었다. 결 론: 소아의 위 점막은 H. pylori 감염 여부에 따라 뚜렷한 유전자 발현의 차이를 보이며, 결절성 위염이 동반된 H. pylori 감염 환자의 위 점막은 일부 유전자에서 발현의 차이를 보이는 것을 알 수 있었다. 향후 추가적인 연구를 통해 소아에서 H. pylori 감염에 의한 결절성 위염의 발병 기전을 밝히려는 시도가 필요할 것이다.

흰쥐의 염산.에탄올 유발 위염 위조직에서 ginsenoside $Rb_1$의 항산화 효과 (Anti-oxidative Effect of Ginsenoside $Rb_1$ on the HCI.Ethanol-Induced Gastric Tissue in Rats)

  • 현진이;김영식;정춘식
    • 생약학회지
    • /
    • 제33권3호통권130호
    • /
    • pp.252-256
    • /
    • 2002
  • In the previous study, we demonstrated that ginsenoside $Rb_1$ isolated from the butanol fraction of the head of Panax ginseng had significant gastroprotective activity on gastritis and gastric ulcer models in rats. It has been well established that drugs to have capacity of scavenging or inhibiting the generation of reactive oxygen radicals prevent the gastric mucosal injury. Ginsenoside $Rb_1$ was tested on HCl ethanol-induced gastritis in rats, DPPH-induced free radical scavenging effect, MDA assay, GSH activity, and SOD activity in gastric tissue. It showed significant inhibition in HCl ethanol-induced gastritis, and al~o significantly increase of GSH activated SOD. We speculate that the protective effect of ginsenoside $Rb_1$ against HCl ethanol-induced gastric mucosal damage is originated from the increase of GSH and the activation of SOD.

Suppressive Actions of Astragali Radix (AR) Ethanol Extract and Isolated Astragaloside I on HCl/ethanol-Induced Gastric Lesions

  • Jeong, Jeong-Suk;Lee, Je-Hyuk;Lee, Sang-Hyup;Kang, Sam-Sik;Jeong, Choon-Sik
    • Biomolecules & Therapeutics
    • /
    • 제17권1호
    • /
    • pp.62-69
    • /
    • 2009
  • Roots of Astragalus membranaceus (A. membranaceus) (Astragali Radix, AR) has been used as a herbal medicine for gastrointestinal disorders in China, Korea, Japan, and other Asia countries. In this study we investigated the effects of the AR 70% ethanol extract and compounds isolated from AR on gastritis in rats and growth of human gastric cancer cells. AR 70% ethanol extract showed the potent acid-neutralizing capacities and partly cytotoxicity of Helicobacter pylori and human AGS gastric cancers cell. Astragaloside I and daucosterol, which were isolated from AR, significantly inhibited HCl/ethanol-induced gastric lesions. In addition, daucosterol increased the mucus content to almost the same as the positive control. The results of this study suggest that astragaloside I and daucosterol may be good candidates for the development of new drugs or neutraceuticals which can be used for the treatment or prevention of gastritis.

엉겅퀴(Cirsium japonicum var. ussuriense)추출물 및 분획물의 항위염 및 항위궤양 효과에 대한 연구 (Antigastritic and Antiulcerative Effects of Cirsium japonicum var. ussuriense Extract and Fractions)

  • 이유미;황인영;이은방;정춘식
    • 약학회지
    • /
    • 제55권2호
    • /
    • pp.160-167
    • /
    • 2011
  • Cirsium japonicum var. ussuriense (CJ) is used as a folk medicine for diuretic, arthritis, dyspepsia, and bleeding in Korea. Until now, more than fifteen kinds of CJ were identified and among them, Cirsium japonicum var. nakaianum Nakai was selected as experimental material. Both that from The Medical Herb Garden of Seoul National University located at Gayang-dong, Koyang city and native that from a hillock near Dangjin, Chungnam were collected and analyzed to determine whether it is varied in efficacy on their habitats. Extracts and fractions of CJ had a strong effect of antibacterial activity on H. pylori and antioxidant effects. And the CJ from Garden and Dangjin were showed to be more efficient in acute gastritis through the HCl${\cdot}$ethanol-induced gastric lesion test and chronic gastritis through the indomethacin-induced gastric lesion test, respectively. This study proved that the effects of CJ are varied by their habitats. Also, these results suggest that the CJ has potentials for use as functional food and medicine.